SPARC promotes widespread adoption of cutting-edge diagnostic tools by:

• Expanding the use of next-generation sequencing
• Supporting the integration of liquid biopsy into clinical workflows
• Enhancing digital pathology and imaging data contributions
• Deploying AI-based tools to assist with variant interpretation and decision-making

These innovations reduce diagnostic delays and help clinicians identify more precise treatment options.

SPARC reinforces the role of MTBs by:

• Providing digital platforms for case sharing
• Enabling participation of experts from multiple countries
• Offering decision-support tools to help interpret molecular findings
• Establishing consistent workflows across institutions

This leads to better coordination, standardisation, and transparency.

The project supports patients by:

• Developing educational resources that explain genomics, biomarkers, and personalised therapies
• Creating digital materials with patient organisations
• Improving cancer literacy
• Supporting patient involvement in developing care pathways

This ensures that personalised medicine remains patient-centered.

SPARC delivers:

• Modular training covering genomics, liquid biopsy, AI interpretation, and ethics
• Real-world case studies for clinicians
• Twinning activities and exchange programmes
• Materials tailored for different professional roles

This helps address Europe’s precision oncology skills gap.

The project develops:

• Policy recommendations aligned with EU strategies
• Sustainability frameworks to maintain personalised medicine beyond the project’s lifetime
• Equity frameworks identifying barriers and proposing solutions